Global CRISPR And Cas Gene Market 2025–2029: Competitive Insights and Opportunities

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The CRISPR And Cas Gene Industry By The Forecast Year 2029?

The crispr and cas gene market size has seen rapid expansion over recent years. It is anticipated to expand from $3.99 billion in 2024 to $4.81 billion in 2025, achieving a compound annual growth rate (CAGR) of 20.8%. This historical growth can be linked to factors such as greater consumer awareness, shifts in consumer values, a surge in celebrity endorsements, the rise of veganism, and enhanced social media influence.

The crispr and cas gene market size is projected to experience substantial growth over the next few years. It will grow to $10.67 billion in 2029 at a compound annual growth rate (CAGR) of 22.0%. This expansion during the forecast period is fueled by elements such as the global proliferation of restrictions, increasing mindful consumer behavior, the introduction of new brands, efforts to inform consumers, and enhanced beauty inclusivity. Significant trends anticipated for this timeframe include technological advancements, innovations in products, the emergence of a circular beauty economy, expansion in the men’s grooming segment, and a focus on social justice and ethical sourcing.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13632&type=smp

Which Major Market Drivers Are Shaping The Future Of The CRISPR And Cas Gene Market?

The increasing emphasis on personalized therapy is anticipated to boost the growth of the CRISPR and Cas gene markets in the future. Personalized therapy functions as a medical framework, utilizing an individual’s unique genetic profile to inform decisions regarding disease diagnosis, treatment, and prevention. In personalized medicine, CRISPR and the Cas gene, particularly Cas9, are employed to enable precise modifications to a person’s genetic material, showing great potential for developing customized treatments for genetic disorders, cancer, and various other medical conditions. For example, in January 2023, the Personalized Medicine Coalition, a US-based professional membership organization, reported that the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Among the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, were classified as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the growing need for personalized therapy will stimulate the expansion of the CRISPR and Cas gene markets.

How Is The CRISPR And Cas Gene Market Segmented?

The crispr and cas genemarket covered in this report is segmented –

1) By Product Type: Kits And Enzymes; Libraries; Design Tool; Antibodies; Other Products Types

2) By Service Type: Cell Line Engineering; gRNA Design; Microbial Gene Editing; DNA Synthesis

3) By Application: Clinical; Financial; Operational And Administrative

4) By End Use: Biotechnology And Pharmaceutical Companies; Academics And Government Research Institutes; Contract Research Organizations (CROs)

Subsegments:

1) By Kits And Enzymes: CRISPR Kits; Cas Enzymes; Grna Synthesis Kits

2) By Libraries: CRISPR Libraries For Gene Knockout; CRISPR Libraries For Gene Activation; Sgrna Libraries

3) By Design Tools: Online Design Platforms; Software For CRISPR Guide RNA Design; Custom Design Services

4) By Antibodies: Antibodies For Cas Proteins; Antibodies For Detection Of Edited Cells; Secondary Antibodies For Immunoassays

5) By Other Product Types: Delivery Systems; CRISPR-Related Consumables; Control Plasmids And Reagents

What Key Innovation Trends Are Fueling Advancements In The CRISPR And Cas Gene Market?

Leading firms in the CRISPR and Cas gene markets are creating advanced products like CRISPR-based cell-based gene therapy, aiming to improve their offerings and secure an edge over competitors. This therapy utilizes CRISPR gene-editing technology to alter or fix genetic material inside cells, providing a precise and potentially transformative method for addressing genetic conditions, illnesses, and various medical issues at a cellular level. As an illustration, in December 2023, the U.S. Food and Drug Administration (FDA) granted approval to Vertex Pharmaceuticals Incorporated, a biopharmaceutical company based in the US, for CASGEVY (exagamglogene autotemcel [exa-cel]). CASGEVY is a CRISPR/Cas9 genome-edited gene therapy designed to manage sickle cell disease (SCD) in patients 12 and above experiencing recurrent vaso-occlusive crises. This medication is unique, presenting the possibility of a single, life-changing treatment for eligible individuals with sickle cell disease. Since administering CASGEVY requires specialized training in stem cell transplantation, Vertex is partnering with seasoned institutions to establish a network of independently owned, approved treatment centers (ATCs) throughout the United States to deliver CASGEVY to patients.

Which Key Market Players Are Investing In Expansion And Innovation Of CRISPR And Cas Gene Market?

Major companies operating in the Crispr and cas gene market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., AstraZeneca plc., Danaher Corporation, Quest Diagnostics, Lonza Group AG, Bio-Rad Laboratories Inc., eGenesis, Novartis Institutes for BioMedical Research, Myriad Genetics Inc., GenScript, Takara Bio Inc., 23andMe Inc., Merck KGaA, Color Genomics Inc., Horizon Discovery Group PLC, Beam Therapeutics Inc., Intellia Therapeutics Inc., New England BioLabs, Recursion Pharmaceuticals Inc., Caribou Biosciences Inc., Cellectis S.A., Editas Medicine Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

Which Region Is Projected To Lead The CRISPR And Cas Gene Market During The Forecast Period?

North America was the largest region in the CRISPR and Cas gene market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR and cas gene market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The CRISPR And Cas Gene Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13632&type=smp

Browse Through More Reports Similar to the Global CRISPR And Cas Gene Market 2025, By The Business Research Company

Nucleic Acid Based Gene Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Dna And Gene Chip Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

Gene Expression Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795